NCT05014230View on ClinicalTrials.gov

Open Label Placebo to Reduce Prescription Opioid Use

NAUnknownINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions
Acute Pain
Interventions
DIETARY_SUPPLEMENT

Open Placebo

Zeebo

OTHER

Opioid medication as part of standard care

Opioid medication as prescribed by prescriber. This is not impacted by being in the research study.

Trial Locations (1)

02912

RECRUITING

Lifespan Hospital System, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

The Miriam Hospital

OTHER

collaborator

Rhode Island Hospital

OTHER

lead

Brown University

OTHER